In their study, CAT improved cancer hypoxia by producing abundant endogenous oxygen, while CD73siRNA efficiently inhibited the expression of the target gene, synergistically down-regulating the level of CD73 and promoting the T cell-specific immune response. The gene discussed is CAT; the disease is cancer.